Novus Biologicals™ Recombinant Human Integrin beta 1/CD29 Protein

Catalog No.	Quantity
NBP259570Y	250 μg
NBP25957050	50 μg

Catalog No. NBP259570Y Supplier Novus Biologicals™ Supplier No. NBP259570250UG

Description

Highly purified. Generating reliable and reproducible results. Applications: SDS-Page

A recombinant protein with a C-Terminal His-tag and corresponding to the amino acids 1-728 of Human Integrin beta 1/CD29 The Recombinant Human Integrin beta 1/CD29 Protein is derived from E. coli. The Recombinant Human Integrin beta 1/CD29 Protein has been validated for the following applications: SDS-Page.

Specifications

• Concentration: 1mg/mL
• For Use With (Application): SDS-PAGE
• Formulation: Liquid. PBS (pH 7.4) containing 10% glycerol
• Gene ID (Entrez): 3688
• Molecular Weight (g/mol): 79.4 kDa
• Name: Recombinant Human Integrin beta 1/CD29 Protein
• Purification Method: >90%, by SDS-PAGE
• Quantity: 250 μg
• Source: Baculovirus
• Storage Requirements: Store at 4°C short term. Aliquot and store at −20°C long term. Avoid freeze-thaw cycles.
• Regulatory Status: RUO
• Endotoxin Concentration: <1.0 EU per 1μg of protein (determined by LAL method)
• Gene Alias: CD29, CD29 antigen, Fibronectin receptor subunit beta, FNRBVLAB, GPIIA, integrin beta-1, integrin VLA-4 beta subunit, integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includesMDF2, MSK12), MDF2, MSK12, very late activation protein, b
• Gene Symbol: ITGB1
• Product Type: Recombinant Protein
• Conjugate: Unconjugated
• Cross Reactivity: Human
• Recombinant: Recombinant

For Research Use Only.